PDF
Word
DOH Form 690-212 Collaborative Drug Therapy Agreement Review Form - Washington
What Is DOH Form 690-212?
This is a legal form that was released by the Washington State Department of Health - a government authority operating within Washington. As of today, no separate filing guidelines for the form are provided by the issuing department.
FAQ
Q: What is DOH Form 690-212?
A: DOH Form 690-212 is the Collaborative Drug Therapy Agreement Review Form in Washington.
Q: What is the purpose of DOH Form 690-212?
A: The purpose of DOH Form 690-212 is to review and document Collaborative Drug Therapy Agreements in Washington.
Q: Who uses DOH Form 690-212?
A: DOH Form 690-212 is used by healthcare professionals in Washington who are involved in Collaborative Drug Therapy Agreements.
Q: What is a Collaborative Drug Therapy Agreement?
A: A Collaborative Drug Therapy Agreement is an agreement between a prescriber and a pharmacist to facilitate patient care.
Q: Is DOH Form 690-212 required for all healthcare professionals in Washington?
A: No, DOH Form 690-212 is only required for healthcare professionals who are involved in Collaborative Drug Therapy Agreements in Washington.
Form Details:
- Released on December 1, 2020;
- The latest edition provided by the Washington State Department of Health;
- Easy to use and ready to print;
- Quick to customize;
- Compatible with most PDF-viewing applications;
- Fill out the form in our online filing application.
Download a printable version of DOH Form 690-212 by clicking the link below or browse more documents and templates provided by the Washington State Department of Health.
Download DOH Form 690-212 Collaborative Drug Therapy Agreement Review Form - Washington
1
2
3
4
